344 related articles for article (PubMed ID: 21697031)
61. [Chronic urticaria, thyroiditis and autologous serum test].
Vermeulen C; Mathelier-Fusade P; Rouquette AM; Bayrou O; Pecquet C; Leynadier F
Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1115-8. PubMed ID: 14724513
[TBL] [Abstract][Full Text] [Related]
62. Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test.
Atwa MA; Emara AS; Youssef N; Bayoumy NM
J Eur Acad Dermatol Venereol; 2014 Apr; 28(4):469-74. PubMed ID: 23451767
[TBL] [Abstract][Full Text] [Related]
63. High prevalence of autoimmune urticaria in children with chronic urticaria.
Brunetti L; Francavilla R; Miniello VL; Platzer MH; Rizzi D; Lospalluti ML; Poulsen LK; Armenio L; Skov PS
J Allergy Clin Immunol; 2004 Oct; 114(4):922-7. PubMed ID: 15480336
[TBL] [Abstract][Full Text] [Related]
64. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria.
Takahagi S; Mihara S; Iwamoto K; Morioke S; Okabe T; Kameyoshi Y; Hide M
Allergy; 2010 May; 65(5):649-56. PubMed ID: 19845571
[TBL] [Abstract][Full Text] [Related]
65. Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria.
Gentinetta T; Pecaric-Petkovic T; Wan D; Falcone FH; Dahinden CA; Pichler WJ; Hausmann OV
J Allergy Clin Immunol; 2011 Dec; 128(6):1227-1234.e5. PubMed ID: 21855127
[TBL] [Abstract][Full Text] [Related]
66. Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study.
Zhong H; Song Z; Chen W; Li H; He L; Gao T; Fang H; Guo Z; Xv J; Yu B; Gao X; Xie H; Gu H; Luo D; Chen X; Lei T; Gu J; Cheng B; Duan Y; Xv A; Zhu X; Hao F
Allergy; 2014 Mar; 69(3):359-64. PubMed ID: 24354882
[TBL] [Abstract][Full Text] [Related]
67. Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study.
Berti A; Yacoub MR; Stahl Skov P; Falkencrone S; Casati L; Burastero S; Sabbadini MG; Colombo G
Eur Ann Allergy Clin Immunol; 2017 Jul; 49(4):154-160. PubMed ID: 28752718
[No Abstract] [Full Text] [Related]
68. Is puncture skin test adequate to detect autoreactivity in patients with chronic urticaria?
Asero R; Tedeschi A
Clin Exp Dermatol; 2008 Nov; 33(6):789-90. PubMed ID: 18627389
[No Abstract] [Full Text] [Related]
69. The Effect of Autologous Serum Therapy in Chronic Spontaneous Urticaria Depends on Autologous Serum Skin Test Positivity.
Elazab SZ; Hessam WF
Egypt J Immunol; 2017 Jun; 24(2):165-172. PubMed ID: 29528589
[TBL] [Abstract][Full Text] [Related]
70. Blood urokinase plasminogen activator system in chronic urticaria.
Kasperska-Zajac A; Brzoza Z; Rogala B
Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
[TBL] [Abstract][Full Text] [Related]
71. The effect of L-thyroxine treatment on chronic idiopathic urticaria and autoimmune thyroiditis.
Magen E; Mishal J
Int J Dermatol; 2012 Jan; 51(1):94-7. PubMed ID: 22182385
[TBL] [Abstract][Full Text] [Related]
72. Different expression patterns of plasma Th1-, Th2-, Th17- and Th22-related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria.
Chen Q; Zhong H; Chen WC; Zhai Z; Zhou Z; Song Z; Hao F
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):441-448. PubMed ID: 28846158
[TBL] [Abstract][Full Text] [Related]
73. Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria.
Metz M; Giménez-Arnau A; Borzova E; Grattan CE; Magerl M; Maurer M
J Allergy Clin Immunol; 2009 Mar; 123(3):705-6. PubMed ID: 19147213
[No Abstract] [Full Text] [Related]
74. Clinical Outcome of Autologous Serum Therapy in Chronic Idiopathic Urticaria.
Karn D; Kc S
J Nepal Health Res Counc; 2017 Jan; 15(1):71-74. PubMed ID: 28714496
[TBL] [Abstract][Full Text] [Related]
75. Chronic idiopathic urticaria: what is the meaning of skin reactivity to autologous serum?
Asero R; Cugno M; Tedeschi A
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):135-6; author reply 136. PubMed ID: 18031493
[No Abstract] [Full Text] [Related]
76. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria.
Baskan EB; Tunali S; Turker T; Saricaoglu H
J Dermatolog Treat; 2004 Jun; 15(3):164-8. PubMed ID: 15204149
[TBL] [Abstract][Full Text] [Related]
77. Usefulness of the CD63 basophil activation test in detecting Anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up.
Frezzolini A; Cadoni S; De Pità O
Clin Exp Dermatol; 2010 Oct; 35(7):765-70. PubMed ID: 19874355
[TBL] [Abstract][Full Text] [Related]
78. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
Lennox RD; Leahy MJ
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673
[TBL] [Abstract][Full Text] [Related]
79. Serum eotaxin levels in patients with chronic spontaneous urticaria.
Tedeschi A; Asero R; Lorini M; Marzano AV; Cugno M
Eur Ann Allergy Clin Immunol; 2012 Oct; 44(5):188-92. PubMed ID: 23156066
[TBL] [Abstract][Full Text] [Related]
80. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation.
Reeves GE; Boyle MJ; Bonfield J; Dobson P; Loewenthal M
Intern Med J; 2004 Apr; 34(4):182-6. PubMed ID: 15086698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
